AI Article Synopsis
- Clinical pathways help unify the approach for diagnosing and treating endocarditis across different clinical-pathologic groups.
- The rise in endocarditis cases in the US now involves higher-risk patients who may face challenges such as high costs, serious risks, or delays due to other health issues.
- This study aimed to outline the decision-making process of a multidisciplinary team dealing with endocarditis across four different clinical groups.
Article Abstract
Clinical pathways can be useful when disparate clinical-pathologic groups converge on a common diagnostic and therapeutic trajectory. The progressive increase in the incidence of endocarditis in the US has included higher-risk subjects whose candidacy for aggressive cardiac surgical intervention may be highly resource-intensive, prohibitively high risk, or delayed and possibly deferred by comorbidities. We sought to define the sequence, application, and resolution of multidisciplinary endocarditis team decision-making in 4 distinct clinical groups.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664974 | PMC |
| http://dx.doi.org/10.1097/HPC.0000000000000224 | DOI Listing |
Publication Analysis
Top Keywords
multidisciplinary pathway
4
pathway diagnosis
4
diagnosis treatment
4
treatment infectious
4
infectious endocarditis
4
endocarditis clinical
4
clinical pathways
4
pathways disparate
4
disparate clinical-pathologic
4
clinical-pathologic groups
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!